Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Higashi

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
The International Journal of Biochemistry & Cell Biology|June 18, 2013
Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexiaTadashi Yoshida, A Michael Tabony, Sarah Galvez, et al.
Biochimica Et Biophysica Acta|May 22, 2002
Distribution of microsomal triglyceride transfer protein within sub-endoplasmic reticulum regions in human hepatoma cellsYusuke Higashi, Hiroyuki Itabe, Hironaga Fukase, et al.
The American Journal of the Medical Sciences|July 13, 2011
Angiotensin II, oxidative stress and skeletal muscle wastingSergiy Sukhanov, Laura Semprun-Prieto, Tadashi Yoshida, et al.
Journal of Lipid Research|April 5, 2005
A redox-sensitive pathway mediates oxidized LDL-induced downregulation of insulin-like growth factor-1 receptorYusuke Higashi, Tao Peng, Jie Du, et al.
Frontiers of Hormone Research|June 20, 2014
Interaction between insulin-like growth factor-1 and atherosclerosis and vascular agingYusuke Higashi, Henry C Quevedo, Summit Tiwari, et al.
FEBS Letters|August 30, 2011
Differential requirement for nitric oxide in IGF-1-induced anti-apoptotic, anti-oxidant and anti-atherosclerotic effectsSergiy Sukhanov, Yusuke Higashi, Shaw-Yung Shai, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 10, 2016
Histone deacetyltransferase inhibitors Trichostatin A and Mocetinostat differentially regulate MMP9, IL-18 and RECK expression, and attenuate Angiotensin II-induced cardiac fibroblast migration and proliferationNaveen K Somanna, Anthony J Valente, Maike Krenz, et al.
Atherosclerosis|December 31, 2014
Insulin-like growth factor I reduces lipid oxidation and foam cell formation via downregulation of 12/15-lipoxygenaseSergiy Sukhanov, Patricia Snarski, Charlotte Vaughn, et al.
Atherosclerosis|May 31, 2016
TRAF3IP2 mediates atherosclerotic plaque development and vulnerability in ApoE(-/-) miceSiva Sankara Vara Prasad Sakamuri, Yusuke Higashi, Sergiy Sukhanov, et al.
Hypertension (Dallas, Tex. : 1979)|August 17, 2011
Angiotensin II upregulates protein phosphatase 2Cα and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wastingA Michael Tabony, Tadashi Yoshida, Sarah Galvez, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
The International Journal of Biochemistry & Cell Biology|June 18, 2013
Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexiaTadashi Yoshida, A Michael Tabony, Sarah Galvez, et al.
Biochimica Et Biophysica Acta|May 22, 2002
Distribution of microsomal triglyceride transfer protein within sub-endoplasmic reticulum regions in human hepatoma cellsYusuke Higashi, Hiroyuki Itabe, Hironaga Fukase, et al.
The American Journal of the Medical Sciences|July 13, 2011
Angiotensin II, oxidative stress and skeletal muscle wastingSergiy Sukhanov, Laura Semprun-Prieto, Tadashi Yoshida, et al.
Journal of Lipid Research|April 5, 2005
A redox-sensitive pathway mediates oxidized LDL-induced downregulation of insulin-like growth factor-1 receptorYusuke Higashi, Tao Peng, Jie Du, et al.
Frontiers of Hormone Research|June 20, 2014
Interaction between insulin-like growth factor-1 and atherosclerosis and vascular agingYusuke Higashi, Henry C Quevedo, Summit Tiwari, et al.
FEBS Letters|August 30, 2011
Differential requirement for nitric oxide in IGF-1-induced anti-apoptotic, anti-oxidant and anti-atherosclerotic effectsSergiy Sukhanov, Yusuke Higashi, Shaw-Yung Shai, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 10, 2016
Histone deacetyltransferase inhibitors Trichostatin A and Mocetinostat differentially regulate MMP9, IL-18 and RECK expression, and attenuate Angiotensin II-induced cardiac fibroblast migration and proliferationNaveen K Somanna, Anthony J Valente, Maike Krenz, et al.
Atherosclerosis|December 31, 2014
Insulin-like growth factor I reduces lipid oxidation and foam cell formation via downregulation of 12/15-lipoxygenaseSergiy Sukhanov, Patricia Snarski, Charlotte Vaughn, et al.
Atherosclerosis|May 31, 2016
TRAF3IP2 mediates atherosclerotic plaque development and vulnerability in ApoE(-/-) miceSiva Sankara Vara Prasad Sakamuri, Yusuke Higashi, Sergiy Sukhanov, et al.
Hypertension (Dallas, Tex. : 1979)|August 17, 2011
Angiotensin II upregulates protein phosphatase 2Cα and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wastingA Michael Tabony, Tadashi Yoshida, Sarah Galvez, et al.
Pageof 7